A First-in-Human, Randomized, Double-Blind, Placebo-Controlled, Single- and Multiple-Ascending Oral Dose Study To Assess the Safety and Tolerability of LFF571 in Healthy Volunteers

Documenti analoghi

• Pharmacokinetics of LFF571 and Vancomycin in Patients with Moderate Clostridium difficile Infections
  di: Bhansali, Suraj G., et al.
  Pubblicazione: (2015)
• Efficacy of LFF571 in a Hamster Model of Clostridium difficile Infection
  di: Trzasko, Anna, et al.
  Pubblicazione: (2012)
• Multicenter, Randomized Clinical Trial To Compare the Safety and Efficacy of LFF571 and Vancomycin for Clostridium difficile Infections
  di: Mullane, Kathleen, et al.
  Pubblicazione: (2015)
• A First-in-Human Randomized, Double-Blind, Placebo-Controlled, Single- and Multiple-Ascending Oral Dose Study of Novel Imidazolopiperazine KAF156 To Assess Its Safety, Tolerability, and Pharmacokinetics in Healthy Adult Volunteers
  di: Leong, F. Joel, et al.
  Pubblicazione: (2014)
• A First-in-Human Randomized, Double-Blind, Placebo-Controlled, Single- and Multiple-Ascending Oral Dose Study of Novel Antimalarial Spiroindolone KAE609 (Cipargamin) To Assess Its Safety, Tolerability, and Pharmacokinetics in Healthy Adult Volunteers
  di: Leong, F. Joel, et al.
  Pubblicazione: (2014)